Capella BioScience
London
About Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies (mAbs). It focuses on the employment of proprietary technologies to discover, develop, and commercialize medicines based on mAbs therapeutics for oncology, autoimmune, and other diseases independently, as well in collaboration with biotechnology and academic partners
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2016)
- Website: fdmdigital.co.uk
- Phone: +447747845906
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/capella-bioscience-132588 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.